Article
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia
6 Jan 2023
Abstract excerpt
Allogeneic hematopoietic cell transplantation (allo-HCT) is a potentially curative treatment for acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). While many factors influence the outcomes of allo-HCT, the independent impact of donor-recipient ABO mismatching remains unclear. Using the Center for International Blood and Marrow Transplant Research (CIBMTR) database, we identified patients aged...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
